353- Sica DA. Pharmacologic issues in treating hypertension in CKD. Adv Chronic Kidney Dis.
2011;18(1):42–7. - Toto RD. Proteinuria reduction: mandatory consideration or option when selecting an antihy-
pertensive agent? Curr Hypertens Rep. 2005;7(5):374–8.
22 Resistant Hypertension and the General Practitioner (Monitoring and Treatment)